Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed)

Funding Agency:
National Institutes of Health

The purpose of the High Impact Specialized Innovation Programs (SIPs) is to support the development and demonstration of unique hub capabilities, research platforms and/or resources to address in a timely manner critical gap areas and/or roadblocks in clinical and translational science at awarded UM1 Clinical and Translational Science Awards (CTSA) Program Hubs (PAR-21-293). Successful programs supported through this funding opportunity are expected to lay a strong foundation for future adoption and/or dissemination of capabilities to additional CTSA Program Hubs.

  • A UM1 hub institution can submit up to two RC2 applications for SIPs per cycle as the primary institution.
  • A CTSA UM1 hub may have up to two RC2 SIPs awards as the primary recipient at a given time.

Interested applicants from within Duke should contact dukeiln@duke.edu as early as possible.

Deadlines:

  • Letter of Intent Due Date(s): 30 days prior to the application due date

  • Application Due Date(s): Jan 26, 2022; May 13, 2022; Sep 16, 2022; Jan 13, 2023; May 12, 2023; Sep 15, 2023; Jan 12, 2024; May 17, 2024; Sep 13, 2024

PAR-21-340 Expiration Date September 14, 2024

Agency Website

Eligibility Requirements

Only the primary UM1 hub institution is eligible to apply (not partner or collaborator institutions).

Only applicants who submit a companion CTSA UM1 hub application or have received a UM1 award to PAR-21-293 are eligible to apply to this RC2 FOA. RC2 applications will only be awarded if there is a funded UM1 application from the RC2 applicant institution. No more than two RC2 applications may be submitted by a UM1 hub recipient. No more than two RC2 applications may be awarded to an active (not in an extension period) CTSA UM1 hub as a primary recipient, at a given time. Resubmission of a RC2 application without the required UM1 application is only allowed if the companion UM1 application is funded.

Collaborations with other components of the CTSA UM1 hub and/or with institutions listed as partners and/or collaborators are encouraged. Also, collaborations with other CTSA UM1 hubs and with non-CTSA institutions are encouraged. The requested project period may be up to 5 years.

The PD/PI or contact PD/PI must be employed by and/or a recipient of funding from a currently funded CTSA Program UM1 hub prime institution as defined above in Eligible Organizations. Investigators who are not employed by and/or a recipient of funding from a CTSA Program UM1 hub institution but who wish to co-lead a SIP, can co-direct in partnership with a contact PD/PI who is employed by a currently funded CTSA Program UM1 hub institution using the multiple PD/PI option.

See required Letters of Support. (see Section IV. Application and Submission Information, 2. Content and Form of Application Submission, PHS 398 Research Plan.

  • A UM1 hub institution can submit up to two RC2 applications for SIPs per cycle as the primary institution.
  • A CTSA UM1 hub may have up to two RC2 SIPs awards as the primary recipient at a given time.

      Amount

      $2,500,000

      Amount Description

      Application budgets are limited to no more than $500,000/year in direct costs excluding consortium/contractual F&A costs.

      Requested project period may be up to 5 years.

        Funding Type

        Award
        Grant

        Eligibility

        Faculty

        Category

        Curriculum Development
        Medical
        Medical - Clinical Science
        Medical - Translational

        External Deadline

        January 26, 2022